FR2938769B1 - Composition cosmetique et/ou pharmaceutique comprenant un hydrolysat de feuille de vigne (vitis viniferal.)en tant que principe actif activateur du cytochrome c - Google Patents

Composition cosmetique et/ou pharmaceutique comprenant un hydrolysat de feuille de vigne (vitis viniferal.)en tant que principe actif activateur du cytochrome c

Info

Publication number
FR2938769B1
FR2938769B1 FR0806629A FR0806629A FR2938769B1 FR 2938769 B1 FR2938769 B1 FR 2938769B1 FR 0806629 A FR0806629 A FR 0806629A FR 0806629 A FR0806629 A FR 0806629A FR 2938769 B1 FR2938769 B1 FR 2938769B1
Authority
FR
France
Prior art keywords
viniferal
hydrolysat
vitis
cytochrome
cosmetic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0806629A
Other languages
English (en)
Other versions
FR2938769A1 (fr
Inventor
Farra Claude Dal
Nouha Domloge
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ISP Investments LLC
Original Assignee
ISP Investments LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ISP Investments LLC filed Critical ISP Investments LLC
Priority to FR0806629A priority Critical patent/FR2938769B1/fr
Publication of FR2938769A1 publication Critical patent/FR2938769A1/fr
Application granted granted Critical
Publication of FR2938769B1 publication Critical patent/FR2938769B1/fr
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/01—Hydrolysed proteins; Derivatives thereof
    • A61K38/011—Hydrolysed proteins; Derivatives thereof from plants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/87—Vitaceae or Ampelidaceae (Vine or Grape family), e.g. wine grapes, muscadine or peppervine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A61K8/645—Proteins of vegetable origin; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/004—Aftersun preparations
FR0806629A 2008-11-26 2008-11-26 Composition cosmetique et/ou pharmaceutique comprenant un hydrolysat de feuille de vigne (vitis viniferal.)en tant que principe actif activateur du cytochrome c Expired - Fee Related FR2938769B1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR0806629A FR2938769B1 (fr) 2008-11-26 2008-11-26 Composition cosmetique et/ou pharmaceutique comprenant un hydrolysat de feuille de vigne (vitis viniferal.)en tant que principe actif activateur du cytochrome c

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0806629A FR2938769B1 (fr) 2008-11-26 2008-11-26 Composition cosmetique et/ou pharmaceutique comprenant un hydrolysat de feuille de vigne (vitis viniferal.)en tant que principe actif activateur du cytochrome c

Publications (2)

Publication Number Publication Date
FR2938769A1 FR2938769A1 (fr) 2010-05-28
FR2938769B1 true FR2938769B1 (fr) 2010-12-31

Family

ID=40973195

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0806629A Expired - Fee Related FR2938769B1 (fr) 2008-11-26 2008-11-26 Composition cosmetique et/ou pharmaceutique comprenant un hydrolysat de feuille de vigne (vitis viniferal.)en tant que principe actif activateur du cytochrome c

Country Status (1)

Country Link
FR (1) FR2938769B1 (fr)

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU1273401A (en) * 2000-04-18 2001-10-30 Ceteris Holding B V Amsterdam A composition based on natural extracts useful in the prevention and treatment of cutaneous wrinkles
FR2808190B1 (fr) * 2000-04-28 2002-06-21 Oreal Extrait de vegetal de l'espece vitis vinifera comme inhibiteur de no-synthase et utilisations
FR2808682B1 (fr) * 2000-05-10 2002-08-16 Michel Fauvel Produit cosmetique a base de cellules vegetales convenant notamment aux soins de la peau
FR2898493B1 (fr) * 2006-03-16 2008-08-08 Af Consulting Compositions cosmetiques, pharmaceutiques, alimentaires et veterinaires dont l'action d'activation de genes de type sirtuin permet de retarder le vieillissement des mammiferes et ses effets nefastes
FR2915380B1 (fr) * 2007-04-27 2012-06-08 Vincience Utilisateur d'un principe actif issu du riz (oryza sativa l) pour preparer une composition destinee a activer le cytochrome c
FR2915381B1 (fr) * 2007-04-27 2012-06-08 Vincience Utilisation d'un principe actif issu du soja (glycine max l) pour preparer une composition destinee a activer le cytochrome c
FR2915382B1 (fr) * 2007-04-27 2012-06-01 Vincience Utilisation d'un principe actif issu du mais (zea mays l) pour preparer une composition destinee a activer le cytochrome c

Also Published As

Publication number Publication date
FR2938769A1 (fr) 2010-05-28

Similar Documents

Publication Publication Date Title
EA201170772A1 (ru) Органические соединения
EA200801164A2 (ru) Ингибиторы протеина, активирующего 5-липоксигеназу (flap)
NO20083780L (no) Topisk sammensetning omfattende en antibakteriell substans
EA201000584A1 (ru) Ингибиторы протеина, активирующего 5-липоксигеназу (flap)
CY1115825T1 (el) Φαρμακευτικες συνθεσεις που περιεχουν λεβετιρακεταμη και διαδικασια παρασκευης τους
BRPI0607198A2 (pt) composição, uso da composição método de tratamento doenças, e, embalagem farmacêutica
ZA200803350B (en) Method of acting upon organism by targeted delivery of biologically active substances into mitochondria, pharmaceutical composition for carrying out said method, and compound used for the purpose
EA200870019A1 (ru) Лактамовые соединения и способы их применения
CL2008000594A1 (es) Uso de compuestos derivados de heterociclos; composicion farmaceutica que comprende a dichos compuestos y otros agentes activos; y su uso para tratar diabetes, enfermedad arterial coronaria entre otras enfermedades.
CL2008000593A1 (es) Uso de compuestos derivados de heterociclos sustituidos; composicion farmaceutica que comprende a dichos compuestos y otros agentes activos; y su uso para tratar diabetes, enfermedad aterosclerotica de las arterias entre otras enfermedades.
WO2007070052A3 (fr) Compositions pharmaceutiques et méthodes destinées à traiter ou prévenir une maladie associée à l'oxalate
EA201001330A1 (ru) Соединения и композиции в качестве модуляторов активности gpr119
BRPI0508540A (pt) composto, composição farmacêutica, e, uso de um composto
BRPI0813926A2 (pt) Utilização de uma substância, composição e métodos de triagem de princípios ativos que inibem a formação dos ages e de cuidado cosmético.
ATE485261T1 (de) Salicylsäurederivate
BRPI0717369A2 (pt) Composto, medicamento, composição farmacêutica que o contém e uso do composto.
FR2918988B1 (fr) Extrait polysaccharidique de lentinus et compositions pharmaceutiques, cosmetiques ou nutraceutiques comprenant un tel extrait.
UY29999A1 (es) "n-pirazinil-fenilsulfonamidas, procedimientos y compuestos intemedios utilizados en su preparacion, composiciones farmaceuticas que las contienen y aplicaciones"
CR10050A (es) Combinacion fungicida de productos activos
ECSP088476A (es) Combinación de productos activos fungicidas
EA200870058A1 (ru) Композиции, содержащие остеопонтин крупного рогатого скота, для улучшения процесса заживления ран
CL2013000709A1 (es) Composicion que contiene nifurtimox y un antihelmintico seleccionado de: pf1022, emopdepsido, tribendimidina, amidantel, bay d 9216, praziquantel o benzoato de bencilo; util en el tratamiento de enfermedades causadas por giardias (div. sol. 1577-10).
BR112012027393A2 (pt) composto da fórmula geral i, composição farmacêutica, uso de um composto e método de tratamento de qualquer mamífero, notadamente um humano, afetado por câncer
WO2010080414A3 (fr) Dérivés de fno (2-[furane-2-yl] naphthalène-1-ol) substitués utilisés comme agents anticancéreux
EA200701688A1 (ru) Замещённые пирролы, содержащие их композиции, способ получения и применение

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 8

PLFP Fee payment

Year of fee payment: 9

PLFP Fee payment

Year of fee payment: 10

PLFP Fee payment

Year of fee payment: 12

ST Notification of lapse

Effective date: 20210706